デフォルト表紙
市場調査レポート
商品コード
1701970

OIS(オンコロジー情報システム)市場:製品・サービス別、用途別、エンドユーザー別、地域別、2025-2033年

Oncology Information Systems Market Report by Product and Services, Application, End User, and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 137 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
OIS(オンコロジー情報システム)市場:製品・サービス別、用途別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

OIS(オンコロジー情報システム)市場の世界市場規模は2024年に42億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに73億米ドルに達し、2025~2033年の成長率(CAGR)は5.95%になると予測しています。

OISとは、がんの診断、患者プロファイルの最適化、生存率向上のための適切な治療法の特定を目的とした包括的な情報・画像管理ソリューションのことです。OISには、スクリーニング、予防、分析、治療、緩和ケアなどが含まれます。従来の技術に比べ、腫瘍学システムは遠隔アクセス、計画的治療、将来予測、臨床および非臨床取得データの適切な管理を提供します。これとは別に、OISは診断の詳細や治療パターンの追跡を支援するため、診療所、研究所、病院、研究センターで広く採用されています。

OIS市場の動向:

OIS市場の主な要因は、タバコの消費量の増加やライフスタイルの進化により、特に高齢者の間で増加しているがんの有病率です。OISは電子カルテ(EHR)を管理し、患者ベースのサービスの向上、疾病メカニズムに関する新たな洞察の創出、疾病の早期発見のほか、より良い治療オプションの提供に役立っています。これに伴い、紙ベースの記録作成、処方、治療計画の誤りを軽減するためのブロックチェーンや人工知能(AI)の統合など、著しい技術的進歩が別の成長促進要因として作用しています。さらに、各国政府は研究開発(R&D)部門に広く資金を投入して遠隔腫瘍学情報システムを導入しており、これにより医療従事者は患者と物理的に同席することなく、モバイルアプリケーションを通じてがんの長期モニタリングを行うことができます。その結果、特にコロナウイルス感染症(COVID-19)が発生し、それに伴う強制閉鎖が実施された際に、ヘルスケア部門全体への導入が強化されました。その他にも、がんモニタリングシステムの利用可能性に関する消費者の意識の高まりや、免疫療法や放射線療法を実施するためのOISの導入が拡大していることなどが、市場に明るい展望をもたらしています。

本レポートで扱う主な質問

  • 2024年の世界のOIS市場の市場規模は?
  • 2025-2033年の世界のOIS市場の予想成長率は?
  • 世界のOIS市場を牽引する主要因は何か?
  • 世界のOIS市場に対するCOVID-19の影響は?
  • 世界のOIS市場の製品・サービス別内訳は?
  • 世界のOIS市場の用途別内訳は?
  • 世界のOIS市場のエンドユーザー別内訳は?
  • 世界のOIS市場における主要地域は?
  • 世界のOIS市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のOIS市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品・サービス別

  • ソフトウェア
    • 主要セグメント
      • 患者情報システム
      • 治療計画システム
  • サービス
    • 主要セグメント
      • コンサルティングサービス
      • 実装サービス
      • メンテナンスサービス

第7章 市場内訳:用途別

  • RO
  • MO
  • SO

第8章 市場内訳:エンドユーザー別

  • 病院・診断イメージングセンター
  • アブレーションケアセンター・がん治療センター
  • 政府機関
  • 研究施設

第9章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳:国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Accuray Incorporated
    • Advanced Data Systems
    • Cerner Corporation(Oracle Corporation)
    • CureMD Healthcare
    • Elekta
    • EndoSoft LLC(Utech Products Inc.)
    • F. Hoffmann-La Roche Ltd
    • Koninklijke Philips N.V.
    • McKesson Corporation
    • OPTUM Inc.(United Healthcare Services Inc.)
    • RaySearch Laboratories
    • Varian Medical Systems Inc
図表

List of Figures

  • Figure 1: Global: Oncology Information Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Oncology Information Systems Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Oncology Information Systems Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Oncology Information Systems Market: Breakup by Product and Services (in %), 2024
  • Figure 5: Global: Oncology Information Systems Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Oncology Information Systems Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Oncology Information Systems Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Oncology Information Systems (Software) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Oncology Information Systems (Software) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Oncology Information Systems (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Oncology Information Systems (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Oncology Information Systems (Radiation Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Oncology Information Systems (Radiation Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Oncology Information Systems (Medical Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Oncology Information Systems (Medical Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Oncology Information Systems (Surgical Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Oncology Information Systems (Surgical Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Oncology Information Systems (Hospitals and Diagnostic Imaging Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Oncology Information Systems (Hospitals and Diagnostic Imaging Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Oncology Information Systems (Ablation Care Centers and Cancer Care Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Oncology Information Systems (Ablation Care Centers and Cancer Care Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Oncology Information Systems (Government Institutions) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Oncology Information Systems (Government Institutions) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Oncology Information Systems (Research Facilities) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Oncology Information Systems (Research Facilities) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Oncology Information Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Oncology Information Systems Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Oncology Information Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Oncology Information Systems Industry: SWOT Analysis
  • Figure 76: Global: Oncology Information Systems Industry: Value Chain Analysis
  • Figure 77: Global: Oncology Information Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncology Information Systems Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Oncology Information Systems Market Forecast: Breakup by Product and Services (in Million USD), 2025-2033
  • Table 3: Global: Oncology Information Systems Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Oncology Information Systems Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Oncology Information Systems Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Oncology Information Systems Market: Competitive Structure
  • Table 7: Global: Oncology Information Systems Market: Key Players
目次
Product Code: SR112025A5898

The global oncology information systems market size reached USD 4.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.95% during 2025-2033.

Oncology information systems (OIS) refers to a comprehensive information and image management solution that is designed for diagnosing, optimizing patient profile, and identifying suitable therapy for cancer to improve survival rate. They involve screening, prevention, analysis, treatment, and palliative care. As compared to conventional techniques, oncology systems offer remote access, planned treatment, future prediction, and proper management of clinical and non-clinical acquired data. Apart from this, OIS assists in keeping track of diagnostic details and treatment patterns, on account of which they are extensively employed in clinics, laboratories, hospitals, and research centers.

Oncology Information Systems Market Trends:

The oncology information systems market is majorly being driven by the increasing prevalence of cancer, especially amongst the rising geriatric population, due to the rising consumption of tobacco-based products and evolving lifestyles. OIS maintains electronic health records (EHR), which further assists in improving patient-based services, generating new insights into disease mechanism, detecting the early spread of the disease, and providing better treatment options. In line with this, significant technological advancements, such as the integration of blockchain and artificial intelligence (AI) to mitigate the errors of paper-based record creation, prescriptions, and treatment plans, is acting as another growth-inducing factor. Additionally, governments of various countries are extensively funding in the research and development (R&D) departments to introduce remote oncology information systems, which enables healthcare practitioners to perform long-term monitoring of cancer through mobile applications, without being physically present with the patient. This, in turn, has intensified their adoption across the healthcare sector, particularly during the ongoing coronavirus disease (COVID-19) and the consequent implementation of mandatory lockdowns. Other factors, such as growing consumer awareness regarding the availability of cancer monitoring systems and the escalating uptake of OIS to perform immunotherapy and radiation therapy, are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Product and Services:

  • Software
  • Patient Information Systems
  • Treatment Planning Systems
  • Services
  • Consulting Services
  • Implementation Services
  • Maintenance Services

Breakup by Application:

  • Radiation Oncology
  • Medical Oncology
  • Surgical Oncology

Breakup by End User:

  • Hospitals and Diagnostic Imaging Centers
  • Ablation Care Centers and Cancer Care Centers
  • Government Institutions
  • Research Facilities

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accuray Incorporated, Advanced Data Systems, Cerner Corporation (Oracle Corporation), CureMD Healthcare, Elekta, EndoSoft LLC (Utech Products Inc.), F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., McKesson Corporation, OPTUM Inc. (United Healthcare Services Inc.), RaySearch Laboratories and Varian Medical Systems Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global oncology information systems market in 2024?
  • 2.What is the expected growth rate of the global oncology information systems market during 2025-2033?
  • 3.What are the key factors driving the global oncology information systems market?
  • 4.What has been the impact of COVID-19 on the global oncology information systems market?
  • 5.What is the breakup of the global oncology information systems market based on the product and services?
  • 6.What is the breakup of the global oncology information systems market based on the application?
  • 7.What is the breakup of the global oncology information systems market based on the end user?
  • 8.What are the key regions in the global oncology information systems market?
  • 9.Who are the key players/companies in the global oncology information systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oncology Information Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Services

  • 6.1 Software
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Patient Information Systems
      • 6.1.2.2 Treatment Planning Systems
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Consulting Services
      • 6.2.2.2 Implementation Services
      • 6.2.2.3 Maintenance Services
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Radiation Oncology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Medical Oncology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Surgical Oncology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Diagnostic Imaging Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ablation Care Centers and Cancer Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Government Institutions
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Research Facilities
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accuray Incorporated
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Advanced Data Systems
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Cerner Corporation (Oracle Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 CureMD Healthcare
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Elekta
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 EndoSoft LLC (Utech Products Inc.)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Koninklijke Philips N.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 McKesson Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 OPTUM Inc. (United Healthcare Services Inc.)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 RaySearch Laboratories
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Varian Medical Systems Inc
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio